newsfilter
← Latest News
PR Newswire·

Aeglea BioTherapeutics Announces Grants of Inducement Awards

Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to...